Opened in 2002, the park is now home to 3 companies and 9 research groups from Universities and centres working in: Stem cells, Oncology, leukaemia and Immunology; Molecular cardiology; Skeletal regeneration; Cell therapy and tissue engineering; Muscular dystrophies; Biomedical quality control; Neurological Disorders and Diabetes.
The infrastructure permits the development of concept to preclinical development based on the state-of-the-art facilities including a animal facility encompassing conventional and SPF small animals and a large animal surgery unit. The Fondazione has recently created a Lazio based pre-clinical to clinical trial platform with CRISC (http://w3.uniroma1.it/crisc/), and is also in an international biomedical portfolio management project (Transvac) involving the European Clinical Research Infrastructure Network (www.ecrin.org)
Recently PSB formed a mutual agreement with Datapharm Australia (www.datapharm.com.au). Datapharm Australia is established as the most experienced Australian Contract Research Organisation (CRO) (est. 1987). Locally based, internationally connected through ‘research point’ (www.researchpoint.com) , Datapharm Australia provides all or part clinical trial services to suit needs of Biotechnology and ‘Big Pharma’ companies Australia wide.
This global link aims primarily to:
•Increase overseas interest and awareness of each party’s capabilities (i.e. of Fondazione Parco Biomedico San Raffaele capabilities in Australia and Datapharm Australia’s capabilities in Italy).
•Enable a pipeline/‘support network’ for Australian and Italian/European biotechnology and pharmaceutical companies to utilise each party’s capacities where appropriate.
Although early days, the future advantages of this collaboration are numerous. Both parties will be able to add value for clients who wish to extend operations, research and/or clinical trial programs offshore in new markets. It will also allow a smooth passage for clients from both Europe and Australia to conduct clinical trials and access research opportunities in new markets. Collaboration and strong relations globally are essential to allow access to more patient numbers for global clinical trials whilst maintaining a high standard of quality.
Australia is one of the highest ranked countries for the biotech industry, home to over 420 companies and has many ongoing clinical trials, while Europe boasts over 1400 companies. Traditionally smaller companies have tended to stay close to home in product validation. This collaboration has been created to open the door to conduct more trials on both continents for companies to augment revenue and add value.
“This collaboration moves the Fondazione’s ongoing strategies to enable bench to bedside research into the global arena, and will offer Italian and European entities the possibility to penetrate one of the most dynamic biotech economies on the planet. The existence of the mutual recognition agreement between Europe and Australia for cGMP products will mean that the costs associated with this market penetrance should be significantly lower through the leveraging of the excellence of both partners.
Essentially it strengthens the efforts of both entities to generate a solid system of biomedical diagnostic and therapeutic validation through clinical trials and complements existing globalisation strategies thereby generating global opportunities for resident biotechnology companies.
Essentially it strengthens the efforts of both entities to generate a solid system of biomedical diagnostic and therapeutic validation through clinical trials and complements existing globalisation strategies thereby generating global opportunities for resident biotechnology companies.”
Marco Baccanti, Director General, Fondazione Parco Biomedico San Raffaele
Jonathan Dando | alfa
First time-lapse footage of cell activity during limb regeneration
25.10.2016 | eLife
Phenotype at the push of a button
25.10.2016 | Institut für Pflanzenbiochemie
Ultrafast lasers have introduced new possibilities in engraving ultrafine structures, and scientists are now also investigating how to use them to etch microstructures into thin glass. There are possible applications in analytics (lab on a chip) and especially in electronics and the consumer sector, where great interest has been shown.
This new method was born of a surprising phenomenon: irradiating glass in a particular way with an ultrafast laser has the effect of making the glass up to a...
Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion
Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
25.10.2016 | Earth Sciences
25.10.2016 | Power and Electrical Engineering
25.10.2016 | Process Engineering